Clinical Trial Update: Taxotere-Enoxaparin-(ENOXA)-Study [Phase 3]

View source ↗

Summary

Phase 3 trial of Taxotere in combination with enoxaparin for non-small cell lung cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Enoxaparin (enoxaparin sodium)
• Taxotere (docetaxel)

Snippet

Sponsor: Hannover Medical School | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: TERMINATED